Editas Medicine (NQ: EDIT )
3.740
+0.030
(+0.81%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Editas Medicine
![](/next-assets/images/schema-image-default.png)
A Preview Of Editas Medicine's Earnings
November 02, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/752824/pharma-researcher.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Editas Medicine
October 18, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/749818/dna-genetic-sequencing-biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Editas Medicine
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/751177/scientist-peers-in-microscope-in-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/17/edit.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/17/image17.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/749667/two-investors-meet-and-discuss.jpg)
![](https://g.foolcdn.com/editorial/images/749321/3-investors-gather-around-a-laptop.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/edit.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/749311/dna-on-monitor-scientists.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/29/nike_-_logo_0.jpg?width=1200&height=800&fit=crop)
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image29.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/25/image26.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20230925062932_are-gene-therapy-stocks-the-markets-next-big-winne.jpg)
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.